Sasmar Pharmaceuticals, a Belgium-based pharmaceutical manufacturer, has acquired Aquatrove Biosciences this week as it continues to expand its portfolio of biotechnology companies that will help improve its product pipeline.

Duke University professors Kevin Schulman, MD, and Barak Richman, JD, PhD, called on the CMS Innovation Center to focus on telemedicine and wearable devices, rather than accountable care organizations (ACOs) which integrate hospitals, to reduce the cost of care.

A letter from Aetna CEO Mark Bertolini obtained by the Huffington Post appears to contradict the insurer’s stance that pulling out of 11 Affordable Care Act (ACA) exchanges wasn’t connected to the government’s antitrust lawsuit against its proposed merger with Humana.

The FDA recently approved a cholesterol-lowering drug capable of preventing significant amounts of deaths, nonfatal MI and strokes. Unfortunately, most patients can’t afford it.  

Jackie Somerville, PhD, RN, chief nursing officer at Boston’s Brigham and Women’s Hospital, is leaving the position Oct. 1, according to the Boston Business Journal.

Health plans purchased through the marketplace might be disproportionately damaging to women, according to a new study from the National Women’s Law Center. 

Despite CMS efforts to tout its new Medicare star ratings system as a transparency move and a consumer-benefiting action, not everybody is on board yet.

Midwest healthcare startups are booming so far this year, according to a new report from Cleveland-based BioEnterprise.